Evidence for targeting of CD38 mRNA by the post-transcriptional regulator protein ZFP36L1 : WestminsterResearch

Title	Evidence for targeting of CD38 mRNA by the post-transcriptional regulator protein ZFP36L1
Authors	Murphy, J.J.
Type	Conference poster
Abstract	Introduction: The ZFP36 family of post-transcriptional regulator proteins include ZFP36, ZFP36L1 and ZFP36L2. These proteins are post-transcriptional regulators of gene expression that bind to adenine uridine rich elements (AREs) in the 3’ untranslated region of mRNAs mediating RNA degradation. ZFP36L1 functions in late B cell development to negatively regulate plasma cell differentiation by targeting mRNAs of important proteins including BLIMP1 and BCL2. Previous “in silico”analysis suggested that ZFP36L1 also targeted CD38 mRNA and we report here on the results of in vitro experiments designed to test this. Materials and Methods: A 3’ luciferase reporter construct was made by cloning the CD38 ARE into the dual reporter plasmid pmirGLO. HEK293T cells were transfected with this construct together with plasmids expressing human ZFP36 proteins or mutant versions of them or control empty plasmids. 48 h later cells were harvested and Luciferase and Renilla signals were measured. Results: ZFP36L1 efficiently reduced luciferase levels compared to control constructs. This effect was not seen with a zinc finger mutant ZFP36L1 construct indicating that intact zinc fingers were required for targeting CD38 mRNA. ZFP36 and ZFP36L2 proteins also appeared capable of targeting the CD38 mRNA in these assays. siRNA mediated knockdown of endogenous ZFP36L1 protein in HeLa cells led to increased CD38 expression as measured by Western Blot analysis and immunofluorescence and flow cytometry. Conclusions: These results show that CD38 mRNA is a target for ZFP36L1 and provide further evidence for ZFP36L1 negatively regulating plasma cell differentiation by targeting mRNAs highly expressed in these cells.
Keywords	ZFP36L1
Year	2015
Conference	4th European Congress of Immunology
Web address (URL) of conference proceedings	http://www.eci-vienna2015.org/

Related outputs

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
Rani, A., Stebbing, J., Giamas, G. and Murphy, J.J. 2019. Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy. Frontiers in endocrinology. 10, p. 245. doi:10.3389/fendo.2019.00245

STAT5 in Cancer and Immunity
Murphy, J.J. and Rani, A. 2016. STAT5 in Cancer and Immunity. Journal of Interferon & Cytokine Research. 36 (4), pp. 226-237. doi:10.1089/jir.2015.0054

The Notch target Hes1, is a STAT5 target gene with implications in cancer
Rani, A., Greenlaw, R., Galustian, C. and Murphy, J.J. 2015. The Notch target Hes1, is a STAT5 target gene with implications in cancer. 2015 Meeting of the ICIS in Bamberg, Germany, October 11th -14th. Bamberg, Germany Oct 2015 doi:10.1016/j.cyto.2015.08.214

Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells
Zekavati, A., Nasir, A., Alcaraz, A., Aldrovandi, M., Marsh, P., Norton, J.D. and Murphy, J.J. 2014. Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells. PLoS ONE. doi:10.1371/journal.pone.0102625

ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA
Nasir, A., Norton, J.D., Baou, M., Zekavati, A., Bijlmakers, M.J., Thompson, S. and Murphy, J.J. 2012. ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA. PLoS ONE. 7 (12), p. e52187. doi:10.1371/journal.pone.0052187

AU-rich RNA binding proteins in hematopoiesis and leukemogenesis
Baou, M., Norton, J.D. and Murphy, J.J. 2011. AU-rich RNA binding proteins in hematopoiesis and leukemogenesis. Blood. 118 (22), pp. 5732-5740. doi:10.1182/blood-2011-07-347237

Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells
Baou, M., Jewell, A.P., Muthurania, A., Wickremasinghe, R.G., Yong, K.L., Carr, R., Marsh, P. and Murphy, J.J. 2009. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia. 23 (5), pp. 986-989. doi:10.1038/leu.2008.340

Post-transcriptional regulator protein ZFP36L1 targeting of Bcl-2 mRNA
Zekavati, A., Marsh, P. and Murphy, J.J. 2009. Post-transcriptional regulator protein ZFP36L1 targeting of Bcl-2 mRNA. 2nd European Congress of Immunology. Berlin, Germany 13 – 16 September 2009

Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line
Nasir, A., Roberts, H., Thompson, S. and Murphy, J.J. 2009. Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line. 2nd European Congress of Immunology. Berlin, Germany 13 – 16 September 2009

TIS11 family proteins and their roles in post-transcriptional gene regulation
Baou, M., Jewell, A.P. and Murphy, J.J. 2009. TIS11 family proteins and their roles in post-transcriptional gene regulation. Journal of Biomedicine and Biotechnology. doi:10.1155/2009/634520

Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line
Nasir, A., Roberts, H., Thompson, S. and Murphy, J.J. 2008. Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line. BSI Immunology Congress. Glasgow 17-21 November 2008

Mode of action of Rituximab in chronic lymphocytic leukaemia: activation of Tis11b, an inducer of mRNA instability and induction of apoptosis
Baou, M., Jewell, A.P., Yong, K.L. and Murphy, J.J. 2008. Mode of action of Rituximab in chronic lymphocytic leukaemia: activation of Tis11b, an inducer of mRNA instability and induction of apoptosis. in: Moreau, I.B. (ed.) Chronic lymphocytic leukemia: new research Nova Science Publishers. pp. 141-155

Permalink - https://westminsterresearch.westminster.ac.uk/item/9v27v/evidence-for-targeting-of-cd38-mrna-by-the-post-transcriptional-regulator-protein-zfp36l1